143 related articles for article (PubMed ID: 18463964)
1. Small cell carcinoma of the prostate treated with amrubicin.
Katou M; Soga N; Onishi T; Arima K; Sugimura Y
Int J Clin Oncol; 2008 Apr; 13(2):169-72. PubMed ID: 18463964
[TBL] [Abstract][Full Text] [Related]
2. [SMALL CELL CARCINOMA OF THE PROSTATE: A CASE REPORT OF RELATIVE LONG-TERM SURVIVAL].
Hirai M; Konishi T; Saito K; Washino S; Kobayashi Y; Nokubi M; Miyagawa T
Nihon Hinyokika Gakkai Zasshi; 2015 Oct; 106(4):280-4. PubMed ID: 26717788
[TBL] [Abstract][Full Text] [Related]
3. Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports.
Suzuki K; Terakawa T; Kimbara S; Toyoda M; Jimbo N; Nakano Y; Minami H; Fujisawa M
Clin Genitourin Cancer; 2020 Jun; 18(3):e324-e329. PubMed ID: 32005612
[No Abstract] [Full Text] [Related]
4. [METASTATIC SMALL CELL CARCINOMA OF THE URINARY BLADDER TREATED WITH SYSTEMIC CHEMOTHERAPY INCLUDING AN AMRUBICIN; A CASE REPORT].
Naito A; Matsumoto A; Odani K; Sato Y; Azuma T; Ishizawa M; Nagase Y; Oshi M; Homma Y
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):34-38. PubMed ID: 28132989
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.
Inoue A; Yamazaki K; Maemondo M; Suzuki T; Kimura Y; Kanbe M; Isobe H; Nishimura M; Saijo Y; Nukiwa T
J Thorac Oncol; 2006 Jul; 1(6):551-5. PubMed ID: 17409916
[TBL] [Abstract][Full Text] [Related]
6. Complete response of esophageal small cell carcinoma amrubicin treatment.
Nagasaki E; Yuda M; Tanishima Y; Arakawa Y; Kobayashi K; Sakuyama T; Inoue D; Nishikawa K; Kobayashi M; Omura N; Kobayashi T; Aiba K
J Infect Chemother; 2013 Aug; 19(4):770-5. PubMed ID: 23160626
[TBL] [Abstract][Full Text] [Related]
7. [A case of giant small cell carcinoma of the prostate].
Yashi M; Suzuki K; Tokue A
Hinyokika Kiyo; 2001 Jan; 47(1):55-7. PubMed ID: 11235225
[TBL] [Abstract][Full Text] [Related]
8. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
9. [A case of small cell lung cancer under hemodialysis with chronic renal failure treated with amrubicin while measuring blood concentration of the drug].
Goto N; Shibuya H; Har K; Hisada T
Nihon Kokyuki Gakkai Zasshi; 2007 Apr; 45(4):337-43. PubMed ID: 17491313
[TBL] [Abstract][Full Text] [Related]
10. Amrubicin monotherapy for elderly patients with previously treated lung cancer.
Nakao M; Oguri T; Suzuki T; Kunii E; Tomita Y; Iwashima Y; Miyazaki M; Maeno K; Sato S; Ueda R
Intern Med; 2010; 49(17):1857-62. PubMed ID: 20823645
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced small cell lung cancer complicated by chronic renal failure treated with amrubicin].
Isogai S; Totani Y; Kohashi Y; Mieno Y; Imizu H; Yoneda Y; Shimizu H; Hoshino T; Uchiyama Y; Takeuchi Y; Hayashi M; Saitoh Y; Sasaki F; Okazawa M; Sakakibara H
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1591-3. PubMed ID: 18799918
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
Asakuma M; Yamamoto M; Wada M; Ryuge S; Katono K; Yokoba M; Fukui T; Takakura A; Otani S; Maki S; Igawa S; Yanaihara T; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Masuda N
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1529-36. PubMed ID: 22415148
[TBL] [Abstract][Full Text] [Related]
13. [The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report].
Ozawa K; Yuhara K; Kotaka H; Kato D; Takai M; Iinuma K; Nakane K; Okamoto K; Koie T
Hinyokika Kiyo; 2020 Apr; 66(4):121-125. PubMed ID: 32483946
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer.
Okamoto I; Hamada A; Matsunaga Y; Sasaki J; Fujii S; Uramoto H; Yamagata H; Mori I; Kishi H; Semba H; Saito H
Cancer Chemother Pharmacol; 2006 Feb; 57(3):282-8. PubMed ID: 16028099
[TBL] [Abstract][Full Text] [Related]
15. Amrubicin for the treatment of advanced lung cancer.
Kurata T
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):171-80. PubMed ID: 19239396
[TBL] [Abstract][Full Text] [Related]
16. Long-term amrubicin chemotherapy for small-cell lung cancer.
Higashiguchi M; Suzuki H; Hirashima T; Kobayashi M; Goya S; Okamoto N; Matsuura Y; Tamiya M; Morishita N; Kawase I
Anticancer Res; 2012 Apr; 32(4):1423-7. PubMed ID: 22493380
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.
Inoue A; Sugawara S; Maemondo M; Mori Y; Oizumi S; Harada M; Taima K; Morikawa N; Ishida T; Kinoshita I; Watanabe H; Suzuki T; Nakagawa T; Saito R; Nukiwa T
Lung Cancer; 2015 Jul; 89(1):61-5. PubMed ID: 26004087
[TBL] [Abstract][Full Text] [Related]
18. [Docetaxel for small cell carcinoma of the prostate with a metastatic pelvic tumor: a case report].
Ishii G; Omono H; Kasai K; Hata K; Kimura T; Suzuki M; Egawa S
Hinyokika Kiyo; 2014 Dec; 60(12):641-4. PubMed ID: 25602482
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer.
Asao T; Nokihara H; Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Yamamoto N; Sekine I; Kunitoh H; Fujiwara Y; Ohe Y
Jpn J Clin Oncol; 2015 Oct; 45(10):941-6. PubMed ID: 26232449
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities.
Kimura T; Kudoh S; Mitsuoka S; Yoshimura N; Tanaka H; Asai K; Kyoh S; Tochino Y; Umekawa K; Hirata K
Anticancer Drugs; 2009 Jul; 20(6):513-8. PubMed ID: 19352172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
